Ophthalmic Suspensions & Solutions

FDF Products - Ophthalmic Suspensions & Solutions

Product Strength Formulation
Bimatoprost + Timolol Maleate Solution 0.03 % w/v + 0.5 % w/v  Ophthalmic solution 
Bimatoprost Solution 0.01 % w/v  Ophthalmic solution 
Brimonidine Tartarate 02 % w/v Ophthalmic solution 
Brimonidine Tartrate + Timolol Maleate 02 %w/v + 0.5 %w/v Ophthalmic solution 
Brinzolamide + Brimonidine Tartrate Suspension 1.0 % w/v + 0.2 % w/v  Ophthalmic suspension 
Brinzolamide Suspension 1.0 % w/v  Ophthalmic suspension 
Dexamethasone Suspension 0.1 % w/v  Ophthalmic suspension 
Dorzolamide Hydrochloride + Timolol Maleate Solution 2.0 % w/v + 0.5 % w/v  Ophthalmic solution 
Dorzolamide Hydrochloride Solution 2 % w/v  Ophthalmic solution 
Timolol Maleate Solution 0.25 % w/v  Ophthalmic solution 

 

FDF Products - Ophthalmic Suspensions & Solutions - Under Development

Product Formulation Filing
Room Temperature Latanoprost (Early development stage) Ophthalmic Solution / Suspension  505(b)(2)
OD/BD dosage offering of Brinzolamide nano suspension Ophthalmic Solution / Suspension  505(b)(2)
Lipid Tears for Dry Eyes Ophthalmic Solution / Suspension  505(b)(2)

Additional Information

Filing

ANDA / EU Dossier under compilation

Share This Product, Choose Your Platform!

related products